KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.79M	-
CFO	Gall Matthew	235.0K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 15

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 10, 2022	Bornstein Jeffrey S	Director	Buy	5,000	$8.87	$44,350.00	+16.6%	-61.5%	-27.1%
Jan 25, 2022	Atillasoy Ercem78	See Remarks	Sell	4,639	$8.24	$38,247.63	-4.4%	-40.1%	-32.3%
Jan 24, 2022	Hallal David79	Director, 10% Owner	Sell	17,100	$8.01	$136,888.92	-0.8%	-40.1%	-34.3%
Jan 20, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	4,656	$8.75	$40,752.11	-1.2%	-26.4%	-38.2%
Jan 20, 2022	Hagen Brett R84	Chief Accounting Officer	Sell	1,563	$8.75	$13,680.31	-2.4%	-26.4%	-38.2%
Jan 20, 2022	Sinha Vikas84	See Remarks	Sell	6,450	$8.75	$56,454.27	-0.7%	-26.4%	-38.2%
Dec 2, 2021	Van Beek Jeroen B85	Chief Commercial Officer	Sell	514	$17.06	$8,770.23	-0.1%	-50.4%	-57.1%
Nov 16, 2021	Van Beek Jeroen B85	Chief Commercial Officer	Sell	15,203	$21.13	$321,262.19	-3.6%	-60.1%	-64.7%
Nov 16, 2021	Leen Ann M.83	Chief Scientific Officer	Sell	20,988	$22.18	$465,559.20	-0.2%	-60.1%	-64.7%
Nov 10, 2021	Jovan-Embiricos Morana87	Director	Sell	800	$24.77	$19,812.00	-	-65.8%	-66.4%

← PrevPage 15Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC